Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Ahorlu, Collins K ^a   Koram, Kwadwo A ^a   Seakey, Atsu K ^b   Weiss, Mitchell G ^c  

^a University of Ghana   (Ghana)

^b Box KW198 ^*  (Ghana)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; MALARIA VACCINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; CHILD; CONTROL STRATEGY; FEMALE; FEVER; GHANA; HOME CARE; HUMAN; INFANT; INFECTION PREVENTION; INTERMITTENT PREVENTIVE TREATMENT; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MORBIDITY; MORTALITY; PARASITE PREVALENCE; PREGNANT WOMAN; PRESCHOOL CHILD; RISK REDUCTION; SINGLE DRUG DOSE; ADULT; ANIMAL; CAREGIVER; CLINICAL TRIAL; DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; QUESTIONNAIRE; TIME; TREATMENT OUTCOME;

ADULT; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CAREGIVERS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; GHANA; HUMANS; INFANT; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 73549119952     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-292     Document Type: Article

References (17)

1. World Health Organization, The Africa Malaria Report WHO, Geneva 2003 (WHO/CDS/MAL/2003.1093)
2. Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. M Adjuik T Smith S Clark J Todd A Garrib Y Kinfu K Kahn M Mola A Ashraf H Masanja K Adazu J Sacarlal N Alam A Marra A Gbangou E Mwageni F Binka, Bull World Health Organ 2006 84 181 188 10.2471/BLT.05.026492 16583076
3. Final Draft Antimalarial Drug Policy for Ghana, Accra. Ghana Health Service, 2004
4. Comparative efficacy of anti malarial drugs including ACTs in the treatment of uncomplicated malaria in young children under 5 in Ghana. KA Koram L Quaye B Abuaku, Acta Trop 2005 95 194 203 10.1016/j.actatropica.2005.06.018 16054584
5. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. KA Koram B Abuaku N Duah N Quashie, Acta Trop 2005 95 194 203 10.1016/j. actatropica.2005.06.018 16054584
6. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian school children. B Landgraf H Kollaritsch G Wiedermann H Wernsdorfer, Trans R Soc Trop Med Hyg 1994 88 440 442 10.1016/0035-9203(94)90424-3 7570837
7. Sociocultural determinants of treatment delay for childhood malaria in southern Ghana. CK Ahorlu KA Koram C Ahorlu D de Savigny M Weiss, Trop Med Int Health 2006 11 1022 1031 10.1111/j.1365-3156.2006.01660.x 16827703
8. Community concepts of malaria-related illness with and without convulsions in southern Ghana. CK Ahorlu KA Koram C Ahorlu D de Savigny M Weiss, Malar J 2005 4 47 10.1186/1475-2875-4-47 16188023
9. Impact of intermittent preventive treatment with sulphadoxine- pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. A Dicko I Sagara MS Sissoko O Guindo AI Diallo M Kone OB Toure M Sacko OK Doumbo, Malar J 2008 7 123 10.1186/1475-2875-7-123 18611271
10. Intermittent treatment for malaria and anaemia control at time of routine vaccination in Tanzania infants: a randomised, placebo-controlled, double-blind trial. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
11. Effect of intermittent treatment with amodiaquine on anaemia and malaria fevers in infants in Tanzania: a randomised placebo-control trial. JJ Massaga AY Kitua MM Lemnge JA Akida LN Malle AM Ronn TG Theander Bygbjerg, Lancet 2003 361 1853 1860 10.1016/S0140-6736(03)13504-0 12788572
12. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. B Cissé C Sokhna D Boulanger J Milet H Bel K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape, Lancet 2006 367 659 67 10.1016/S0140-6736(06)68264-0 16503464
13. Kish Leslie, Survey Sampling John Wiley & Sons, NY 1965
14. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood, BMJ 2005 331 727 733 10.1136/bmj.331.7519.727 16195288
15. Is the expanded programme on immunization the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa. D Chandramohan J Webster L Smith T Awine S Owusu-Agyei I Carneiro, Trop Med Int Health 2007 12 743 50 17550471
16. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? CM Zikusooka D McIntyre KI Barnes, Malar J 2008 7 176 10.1186/1475-2875-7-176 18793410
17. The evidence base on the cost-effectiveness of malaria control measures in Africa. CA Goodman AJ Mills, Health Policy Plan 1999 14 301 312 10.1093/heapol/14.4.301 10787646